146 related articles for article (PubMed ID: 28285683)
1. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature.
Durieux V; Coureau M; Meert AP; Berghmans T; Sculier JP
Lung Cancer; 2017 Apr; 106():102-109. PubMed ID: 28285683
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 2: Hematologic, cutaneous and vascular syndromes.
Holbrechts S; Gorham J; Sideris S; Meert AP; Durieux V; Berghmans T; Sculier JP
Lung Cancer; 2017 Apr; 106():93-101. PubMed ID: 28285701
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.
Bentea G; Sculier C; Grigoriu B; Meert AP; Durieux V; Berghmans T; Sculier JP
Lung Cancer; 2017 Apr; 106():83-92. PubMed ID: 28285700
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.
Ruelle L; Bentea G; Sideris S; El Koulali M; Holbrechts S; Lafitte JJ; Grigoriu B; Sculier C; Meert AP; Durieux V; Berghmans T; Sculier JP
Lung Cancer; 2017 Sep; 111():150-163. PubMed ID: 28838388
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.
Sculier C; Bentea G; Ruelle L; Grigoriu B; Coureau M; Gorham J; Sideris S; Holbrechts S; Lafitte JJ; Meert AP; Durieux V; Berghmans T; Sculier JP
Lung Cancer; 2017 Sep; 111():164-175. PubMed ID: 28838389
[TBL] [Abstract][Full Text] [Related]
6. [Oncorheumatology: relationship between malignancies and musculoskeletal diseases].
Szekanecz Z; Gomez I; Soós B; Bodoki L; Szamosi S; András C; Juhász B; Váróczy L; Antal-Szalmás P; Szodoray P; Bittner N; Árkosy P; Illés Á; Szűcs G; Dankó K; Bender T; Tamási L; Szekanecz É
Orv Hetil; 2020 Jul; 161(28):1151-1165. PubMed ID: 32609623
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.
Rugienė R; Dadonienė J; Aleknavičius E; Tikuišis R; Distler J; Schett G; Venalis P; Venalis A
Clin Rheumatol; 2011 Mar; 30(3):373-80. PubMed ID: 21225302
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic autoimmune disorders].
Hirokawa M
Gan To Kagaku Ryoho; 2010 Jun; 37(6):980-3. PubMed ID: 20567097
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic rheumatic syndromes].
Pileckyte M; Baliūnaite R; Tamulaitiene V
Medicina (Kaunas); 2003; 39(5):443-7. PubMed ID: 12794365
[TBL] [Abstract][Full Text] [Related]
10. Repercussions of occult malignancy - an etiologic basis for rheumatic disease.
Johnson AK
Med Hypotheses; 2013 Apr; 80(4):447-51. PubMed ID: 23357672
[TBL] [Abstract][Full Text] [Related]
11. Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity.
Manger B; Schett G
Clin Immunol; 2018 Jan; 186():67-70. PubMed ID: 28736272
[TBL] [Abstract][Full Text] [Related]
12. Negative-antibody paraneoplastic syndrome complicating small cell carcinoma.
Farrugia ME
Scott Med J; 2001 Aug; 46(4):117-8. PubMed ID: 11676043
[TBL] [Abstract][Full Text] [Related]
13. Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy).
Naschitz JE; Rosner I
Curr Opin Rheumatol; 2008 Jan; 20(1):100-5. PubMed ID: 18281865
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic syndromes associated with gynecological cancers: A systematic review.
Viau M; Renaud MC; Grégoire J; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Sep; 146(3):661-671. PubMed ID: 28655412
[TBL] [Abstract][Full Text] [Related]
15. Regression of Paraneoplastic Rash after Lung Cancer Chemotherapy.
Pinato DJ; Newsom-Davis T
J Thorac Oncol; 2018 Jan; 13(1):139-140. PubMed ID: 29042270
[No Abstract] [Full Text] [Related]
16. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
Alias A; Rodriguez EJ; Bateman HE; Sterrett AG; Valeriano-Marcet J
Bull NYU Hosp Jt Dis; 2012; 70(2):109-14. PubMed ID: 22892000
[TBL] [Abstract][Full Text] [Related]
17. Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
Miret M; Horváth-Puhó E; Déruaz-Luyet A; Sørensen HT; Ehrenstein V
PLoS One; 2017; 12(8):e0181564. PubMed ID: 28767671
[TBL] [Abstract][Full Text] [Related]
18. Some unusual paraneoplastic syndromes. Case 4. Paraneoplastic nephrotic syndrome in a patient with lung cancer.
Ebert B; Shaffer K; Rennke H
J Clin Oncol; 2003 Jul; 21(13):2624-5. PubMed ID: 12829687
[No Abstract] [Full Text] [Related]
19. Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis.
Wen J; Ouyang H; Yang R; Bo L; Zhang Y; Tang M; Liu Z
Sci Rep; 2018 Jan; 8(1):1786. PubMed ID: 29379092
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic bullous pemphigoid associated with lung cancer].
Safini F; Tawfiq N
Pan Afr Med J; 2015; 21():248. PubMed ID: 26526772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
